The global demand for Isoprenaline (Isoproterenol) Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period of 2021 - 2027. Regarding volume, the market was calculated XX Kilo Tons in 2020 and forecast to touch XX Kilo Tons by 2027 with a CAGR of XX% during 2021-2027.
Isoprenaline or isoproterenol is a non-selective beta-adrenergic receptor agonist that received FDA grant on 19 February 1948. It is a medication used to treat heart block and episodes of Adams-Stokes syndrome. It is also used in emergencies for cardiac arrest and acts as an adjunct in the treatment of hypovolemic shock, septic shock, low cardiac output states, congestive heart failure, and cardiogenic shock. Isoprenaline works based on its positive inotropic and chronotropic effects, which increase cardiac output by increasing the heart rate and cardiac contractility. It also decreases diastolic blood pressure by lowering peripheral vascular resistance. It is sold under the brand name including Isuprel, Isolin, Isoprin, Isosol, Autohaler, among others.
Asthma and heart disease prevalence has grown worldwide, resulting in a parallel requirement for isoprenaline. Expanding aging population contributes to increasing prevalence and risk of cardiovascular disease. Asthma affected an estimated 262 million individuals in 2019 and caused 461000 deaths. Cardiovascular diseases cause 17.9 million deaths annually, which is an estimated 31% of all deaths worldwide. In 2019, people 65 years or over were 703 million. The number of older persons is projected to double to 1.5 billion in 2050. All of these will reflect positively on the global isoprenaline market. A growing number of approvals are granted to companies to develop, manufacture, and sell isoprenaline to meet the global demand. However, fluctuation in raw material prices is likely to hamper the global isoprenaline market in the coming year.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of isoprenaline (isoproterenol). The growth and trends of Isoprenaline (Isoproterenol) Industry provide a holistic approach to this study.
This section of the isoprenaline (isoproterenol) market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Chronic Heart Failure
- Myocardial Infarction
- Postoperative Hypotension
This section covers the regional outlook, which accentuates current and future demand for the Isoprenaline (Isoproterenol) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Isoprenaline (Isoproterenol) Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the isoprenaline (isoproterenol) market include Ivax Pharmaceuticals, Physicians Total Care, Baxter Healthcare, Sanofi, Teva Canada, Pfizer, Bedford Laboratories, Novartis, Sterimax, and Teligent. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.